We are excited to be working with Texas Tech University on the recently funded National Science Foundation grant project entitled, Design of functionally-tested, genomics-informed personalized cancer therapy drug treatment plans.  This project is led by Dr. Ranadip Pal at TTU, with Dr. Keller at cc-TDI as co-investigator. The goal?  Mathematical approaches to combining personalized, synergistic drugs for relapsed cancer… with patient safety in mind.     

Share This